González-Ruiz Francisco J
Department of Cardiovascular Critical Care, National Institute of Cardiology "Dr. Ignacio Chávez", México City, Mexico.
Ann Med Surg (Lond). 2022 May;77:103709. doi: 10.1016/j.amsu.2022.103709. Epub 2022 May 8.
The impact on mortality associated with covid-19 today exceeds five million deaths worldwide, and the number of deaths continues to rise. The complications of the survivors, socio-economic implications at a global level, economic limitations in the health systems, and physical and emotional exhaustion of health personnel are detrimental. Therapeutic strategies are required to limit the evolution of the disease, improve the prognosis of critically ill patients, and, in countries with low purchasing power, create affordable alternatives that can help contain the evolution towards the severity of infected people with mild to moderate symptoms. The misinformation and myths that today are more frequent on social networks and the implementation of practices without scientific support is a problem that aggravates the general panorama. This review aims to concentrate on the best evidence for treating SARS-CoV-2 infection in a simple and summarized manner, addressing therapies from their bases to the most innovative alternatives available today.
如今,新冠疫情对全球死亡率的影响已超过500万例死亡,且死亡人数仍在持续上升。幸存者的并发症、全球层面的社会经济影响、卫生系统的经济限制以及医护人员的身心疲惫都很不利。需要采取治疗策略来限制疾病的发展,改善重症患者的预后,并且在购买力较低的国家,创造出可负担得起的替代方案,以帮助控制轻症至中症感染者向重症发展。如今,社交网络上频繁出现的错误信息和谣言以及无科学依据的做法的实施,是一个加剧整体局面的问题。本综述旨在以简单扼要的方式聚焦于治疗新冠病毒感染的最佳证据,从基础疗法到目前可用的最具创新性的替代疗法进行阐述。